Cite
Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells.
MLA
Chen, Dongzhi, et al. “Study of the Adoptive Immunotherapy on Rheumatoid Arthritis with Thymus-Derived Invariant Natural Killer T Cells.” International Immunopharmacology, vol. 67, Feb. 2019, pp. 427–40. EBSCOhost, https://doi.org/10.1016/j.intimp.2018.12.040.
APA
Chen, D., Liu, H., Wang, Y., Chen, S., Liu, J., Li, W., Dou, H., Hou, W., & Meng, M. (2019). Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells. International Immunopharmacology, 67, 427–440. https://doi.org/10.1016/j.intimp.2018.12.040
Chicago
Chen, Dongzhi, Huifang Liu, Yuanyuan Wang, Shengde Chen, Jialin Liu, Wenjuan Li, Haiyang Dou, Wenguang Hou, and Ming Meng. 2019. “Study of the Adoptive Immunotherapy on Rheumatoid Arthritis with Thymus-Derived Invariant Natural Killer T Cells.” International Immunopharmacology 67 (February): 427–40. doi:10.1016/j.intimp.2018.12.040.